Disruption of GPR35 Signaling in Bone Marrow-Derived Cells Does Not Influence Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Disruption of GPR35 Signaling in Bone Marrow-Derived Cells Does Not Influence Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice. / Baumgartner, Roland; Casagrande, Felipe B.; Mikkelsen, Randi B.; Berg, Martin; Polyzos, Konstantinos A.; Forteza, Maria J.; Arora, Aastha; Schwartz, Thue W.; Hjorth, Siv A.; Ketelhuth, Daniel F. J.
In: Metabolites, Vol. 11, No. 7, 411, 2021.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Disruption of GPR35 Signaling in Bone Marrow-Derived Cells Does Not Influence Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice
AU - Baumgartner, Roland
AU - Casagrande, Felipe B.
AU - Mikkelsen, Randi B.
AU - Berg, Martin
AU - Polyzos, Konstantinos A.
AU - Forteza, Maria J.
AU - Arora, Aastha
AU - Schwartz, Thue W.
AU - Hjorth, Siv A.
AU - Ketelhuth, Daniel F. J.
PY - 2021
Y1 - 2021
N2 - G-protein-coupled receptor-35 (GPR35) has been identified as a receptor for the tryptophan metabolite kynurenic acid (KynA) and suggested to modulate macrophage polarization in metabolic tissues. Whether GPR35 can influence vascular inflammation and atherosclerosis has however never been tested. Lethally irradiated LdlrKO mice were randomized to receive GPR35KO or wild type (WT) bone marrow transplants and fed a high cholesterol diet for eight weeks to develop atherosclerosis. GPR35KO and WT chimeric mice presented no difference in the size of atherosclerotic lesions in the aortic arch (2.37 +/- 0.58% vs. 1.95 +/- 0.46%, respectively) or in the aortic roots (14.77 +/- 3.33% vs. 11.57 +/- 2.49%, respectively). In line with these data, no changes in the percentage of VCAM-1+, IA(b) + cells, and CD3+ T cells, as well as alpha smooth muscle cell actin expression, was observed between groups. Interestingly, the GPR35KO group presented a small but significant increase in CD68+ macrophage infiltration in the plaque. However, in vitro culture experiments using bone marrow-derived macrophages from both groups indicated that GPR35 plays no role in modulating the secretion of major inflammatory cytokines. Our study indicates that GPR35 expression does not play a direct role in macrophage activation, vascular inflammation, and the development of atherosclerosis.
AB - G-protein-coupled receptor-35 (GPR35) has been identified as a receptor for the tryptophan metabolite kynurenic acid (KynA) and suggested to modulate macrophage polarization in metabolic tissues. Whether GPR35 can influence vascular inflammation and atherosclerosis has however never been tested. Lethally irradiated LdlrKO mice were randomized to receive GPR35KO or wild type (WT) bone marrow transplants and fed a high cholesterol diet for eight weeks to develop atherosclerosis. GPR35KO and WT chimeric mice presented no difference in the size of atherosclerotic lesions in the aortic arch (2.37 +/- 0.58% vs. 1.95 +/- 0.46%, respectively) or in the aortic roots (14.77 +/- 3.33% vs. 11.57 +/- 2.49%, respectively). In line with these data, no changes in the percentage of VCAM-1+, IA(b) + cells, and CD3+ T cells, as well as alpha smooth muscle cell actin expression, was observed between groups. Interestingly, the GPR35KO group presented a small but significant increase in CD68+ macrophage infiltration in the plaque. However, in vitro culture experiments using bone marrow-derived macrophages from both groups indicated that GPR35 plays no role in modulating the secretion of major inflammatory cytokines. Our study indicates that GPR35 expression does not play a direct role in macrophage activation, vascular inflammation, and the development of atherosclerosis.
KW - atherosclerosis
KW - GPR35
KW - inflammation
KW - immunometabolism
KW - kynurenine
KW - tryptophan
KW - macrophages
KW - KYNURENIC ACID
U2 - 10.3390/metabo11070411
DO - 10.3390/metabo11070411
M3 - Journal article
C2 - 34201526
VL - 11
JO - Metabolites
JF - Metabolites
SN - 2218-1989
IS - 7
M1 - 411
ER -
ID: 275484379